Skip to Content

Rigosertib

Rigosertib is a multi-kinase inhibitor and selective anticancer compound that induces cell apoptosis by inhibiting PI3K/Akt pathway, promoting phosphorylation of histone H2AX and inducing G2/M phase arrest in the cell cycle. Rigosertib is a selective non-ATP-competitive PLK1 inhibitor.
SKU: SLB-IR2440-1mg
Supplier: Solarbio
Unit: bottle
Price
82.55 € 82.55 €
 Terms and Conditions